The authors – CM Wittich, CM Burkle, and WL Lanier – offer a concise review of the topic of off-label drug use including its definition, prevalence, and implications for drug safety. ربح مال حقيقي من النت The article format addresses 10 common questions and their answers about off-label drug use. The breadth of application, its acceptance, and the liabilities of off-label use are explored. A history of FDA regulations surrounding the practice is presented, which helps to put its evolution into proper perspective. Off-label use, which occurs in every medical specialty, is more common in patient populations not likely to be included in clinical trials (e. كازينو قطر g., pediatric, pregnant, or psychiatric patients). Once a medication is marketed, the FDA does not limit or control how the medication is prescribed by physicians. The pros and cons of the distribution of information regarding the off-label use of medications by pharmaceutical companies, the use of informed consent, and the liability of prescribing physicians are discussed. كيفية لعب القمار
Source: Mayo Clinic Proceedings – pdf of full article.